IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 09/22/20

IPA Europe Significantly Expands its Capabilities, Releasing its Second-Generation B Cell Select ™ PR Newswire VICTORIA, BC, Sept. 22, 2020 VICTORIA, BC , Sept. 22, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE...

ImmunoPrecise Antibodies  ( OTCQB:IPATF ) announces a research collaboration with Zymeworks (NYSE: ZYME ) giving the Company access to Zymeworks' Azymetric and EFECT platforms for the further development of its multiple antibody candidates to fight COVID-19. More news on: ImmunoP...

VICTORIA, BC, Sept. 17, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development,  announce a research collaboration with Zymeworks Inc.,...

VICTORIA, BC , Sept. 10, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) ( FSE:TQB2), a provider of best-in-class therapeutic antibody discovery capabilities for the global pharmaceutical and biotech industries, is pleased ...

ImmunoPrecise Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference) Canada NewsWire VICTORIA, BC, Sept. 9, 2020 VICTORIA, BC, Sept. 9, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (t...

IPA CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th Canada NewsWire VICTORIA, BC, Sept. 8, 2020 VICTORIA, BC , Sept. 8, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA...

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

VICTORIA, BC / ACCESSWIRE / August 31, 2020 / IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV:IPA)(OTCQB:IPATF)(FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced today announced that CEO Jennifer Bath will present to investors a...

ImmunoPrecise Reports Record Revenues and Positive Adjusted EBITDA Fiscal 2020 Canada NewsWire VICTORIA, BC, Aug. 31, 2020 Reports rapid advancement of COVID-19 antibody programs; combination studies achieve nearly complete neutralization of SARS-CoV-2 VICTORIA, BC , ...

IPA Appoints New York Based Crescendo Communications as Investor Relations and Corporate Communications Advisor Canada NewsWire VICTORIA, BC, Aug. 13, 2020 VICTORIA, BC , Aug. 13, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) ...